Antihypertensive therapy in pregnancy.

Area of Science:

• Obstetrics and Gynecology
• Cardiology
• Pharmacology

Background:

• Antihypertensive therapy in pregnancy aims to prevent maternal target organ damage and prolong gestation.
• Current evidence on the benefits of managing hypertension during pregnancy is limited and inconclusive.
• Existing studies often fail to differentiate between types of hypertensive disorders in pregnancy.

Purpose of the Study:

• To review the rationale for using specific antihypertensive drugs in pregnant individuals.
• To identify critical knowledge gaps in the therapeutic management of hypertension during pregnancy.
• To inform future research directions for optimizing antihypertensive treatment in pregnancy.

Main Methods:

• Systematic review of existing literature on antihypertensive therapy in pregnancy.
• Analysis of factors limiting current research conclusions, including diagnostic criteria and measurement techniques.
• Evaluation of the basis for drug selection in managing pregnancy-induced hypertension.

Main Results:

• The precise benefits of antihypertensive therapy in pregnancy are not definitively established.
• Inconsistent diagnostic criteria and blood pressure measurement methods (e.g., oscillometric vs. auscultation) hinder robust conclusions.
• Significant shortcomings exist in the current understanding of effective antihypertensive drug use during pregnancy.

Conclusions:

• Further high-quality studies are essential to clarify the role and efficacy of antihypertensive drugs in pregnancy.
• Standardized diagnostic criteria and consistent blood pressure measurement are crucial for future research.
• Addressing therapeutic knowledge gaps will improve management of hypertensive disorders in pregnancy.